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L-selectin has been suggested to play a role in the pathogenesis of experimental
autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. Here we
demonstrate that L-selectin–/– SJL mice are susceptible to proteolipid protein (PLP)-induced
EAE because the compromised antigen-specific T cell proliferation in peripheral lymph
nodes is fully compensated by the T cell response raised in their spleen. Transfer of PLP-
specific T cells into syngeneic recipients induced EAE independent of the presence or
absence of L-selectin on PLP-specific T cells or in the recipient. Leukocyte infiltration into
the central nervous systemparenchymawasdetectable independent of themode of disease
induction and the presence or absence of L-selectin. In addition, we found L-selectin–/–
C57BL/6mice to be susceptible tomyelin oligodendrocyte glycoprotein-induced EAE. Taken
together, we demonstrate that in SJL and C57BL/6 mice L-selectin is not required for EAE
pathogenesis. The apparent discrepancy of our present observation to previous findings,
demonstrating a role of L-selectin in EAE pathogenesis in C57BL/6 mice or myelin-basic
protein (MBP)-specific TCR-transgenic B10.PL mice, may be attributed to background genes
rather than L-selectin and to a unique role of L-selectin in EAE pathogenesis in MBP-TCR-
transgenic mice.
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Introduction
In multiple sclerosis (MS), and in its animal model, experimental
autoimmune encephalomyelitis (EAE), circulating immune cells
gain access to the CNS and cause inflammation, blood-brain
barrier (BBB) breakdown and demyelination, all of which set the
stage for the development of the clinical manifestations of this
disabling disease. EAE is a T cell-mediated autoimmune disease,
which can be either actively induced (aEAE) by immunizationwith
myelin antigens or by the transfer of encephalitogenic myelin-
specific T cells in susceptible rodents including several mouse
strains. In the SJL mouse, EAE is mostly induced by immunization
with a proteolipid protein (PLP) peptide (amino acids 139–151,
PLPaa139–151) or the adoptive transfer of the respective PLP-specific
CD4+ T cell blasts into syngeneic recipients. Similarly, in the
C57BL/6 mouse, EAE is most commonly induced by immunization
with a myelin oligodendrocyte glycoprotein (MOG) peptide
(amino acids 35–55, MOGaa35–55) or by the adoptive transfer of
the respective MOG-specific CD4+ T cell blasts into – usually
sublethally irradiated – syngeneic recipients. Interaction of
circulating immunocompetent cells with the BBB endothelium
is a critical step in the pathogenesis of CNS inflammation during
EAE.
The recruitment of specific leukocyte subsets from the blood
stream into distinct tissues is mediated by the sequential
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interaction of different adhesion and signaling molecules on
leukocytes and the endothelial cells lining the vessel wall
(reviewed by [1]). The multi-step interaction starts with an initial
transient contact of the circulating leukocyte with the vascular
endothelium, mediated by adhesion molecules of the selectin
family and their respective carbohydrate ligands, or by a4
integrins. After the initial tether, the leukocyte rolls along the
vascular wall with greatly reduced velocity. The rolling leukocyte
can then bind chemotactic factors from the family of chemokines
presented on the endothelial surface. Chemokines bind to
serpentine receptors on the leukocyte surface delivering a
G protein-mediated inside-out signal to integrins present on the
leukocyte surface, thereby enhancing their avidity. Only integrins
with increased avidity are able to mediate the firm adhesion of the
leukocytes to the vascular endothelium by binding to their
endothelial ligands of the immunoglobulin (Ig) superfamily. This
ultimately leads to diapedesis of the leukocyte.
It is generally accepted that a4 integrins play a predominant
role inTcell trafficking across the BBB during EAE, as theymediate
both T cell rolling and firm adhesion of T cells to the BBB
(summarized in [2]). In contrast, the adhesion molecules
generally mediating leukocyte rolling along the vascular wall,
such as P-selectin glycoprotein ligand (PSGL-1) [3, 4] or its
endothelial ligands E- and P-selectin, are not required for the
development of EAE in C57BL/6 and SJL mice [5, 6]. Similarly,
L-selectin has been shown in antibody blocking experiments to
play no role in the recruitment of inflammatory cells across the
BBB during EAE [7]; nevertheless, its role in EAE pathogenesis
remains controversial [8, 9].
L-selectin was first described as the peripheral lymph node
(PLN)-homing receptor, defined by the mAb Mel 14, which blocks
T cell rolling on high endothelial venules in PLN [10, 11]. Later, it
was discovered that L-selectin is expressed on almost all leukocyte
subpopulations including neutrophils and monocytes/macro-
phages. Thus, besides its role in immunosurveillance, L-selectin
has been shown to mediate inflammatory cell recruitment to a
variety of sites of inflammation (summarized in [12]). In addition,
studies performed in L-selectin-deficient mice have demonstrated
an involvement of L-selectin in the generation of primary T cell
responses [13, 14], suggesting a potential role of L-selectin in the
development of autoimmune diseases.
As mentioned above, investigations on the role of L-selectin in
EAE pathogenesis have produced controversial results. Antibody
inhibition studies performed in passive transfer EAE models in the
Lewis rat or the (PLxSJL)F1 mouse failed to demonstrate any role
of L-selectin in EAE pathogenesis [7, 15]. In contrast, anti-L-
selectin antibodies block the development of aEAE in the Lewis rat
[15]. Furthermore, L-selectin-deficient C57BL/6 mice were
reported to be resistant to EAE due to the failure of encephalito-
genic T cell priming [8], whereas L-selectin-deficient myelin-basic
protein (MBP)-specific TCR transgenic B10.PL mice failed to
develop clinical EAE due to a requirement of L-selectin for effector
functions of CNS inflammatory cells [9].
To obtain more insight into the role of L-selectin in EAE
pathogenesis we decided to investigate its role in EAE pathogenesis
in the SJL mouse model, which allows both the induction of active
EAE by immunization with myelin antigen and adoptive transfer of
EAE with PLP-specific CD4+ T cells without further manipulation
of the mice such as sublethal irradiation as required in the
C57BL/6 mouse model. Furthermore, studies in the SJL EAE
models have allowed the definition of the role of a4 integrins in
inflammatory cell trafficking across the BBB [16, 17], a finding
that has been translated into a novel therapy for relapsing-
remitting MS with the anti-a4 integrin antibody natalizumab. We
have backcrossed L-selectin-deficient mice for at least 11 and up
to 18 generations into the SJL background. Here, we show that
L-selectin–/– SJL mice are neither resistant to active EAE induced
by immunization with PLPaa139–151 nor to EAE passively trans-
ferred by PLP-specific T cells. Furthermore, L-selectin is not
required on PLP-specific Tcells to transfer EAE or on inflammatory
cells to enter the CNS parenchyma. Additionally, we have
backcrossed L-selectin-deficient mice for 18 generations into the
C57BL/6 background and found that these mice are susceptible to
EAE. Thus, in the C57BL/6 as in the SJLmouse L-selectin is neither
required for immune cell trafficking to the CNS nor for the
priming, clonal expansion and effector function of encephalito-
genic T cells. Our results suggest that the previously reported role
of L-selectin in establishing clinical EAE is unique to MBP-TCR
B10.PL mice [9] and that sufficient backcrossing is required to be
able to distinguish a role of L-selectin from that of other mouse
background genes in EAE pathogenesis.
Results
Anti-L-selectin antibody Mel-14 does not inhibit aEAE
in the SJL mouse
It has been reported that anti-L-selectin antibodies block aEAE, but
fail to inhibit adoptively transferred EAE. Antibody inhibition
studies were performed to test whether treatment of SJL mice with
the anti-L-selectin antibody Mel-14 blocks aEAE induced by
immunization of SJL mice with PLPaa139–151 in CFA. Interestingly,
despite detectable serum levels of the antibody, Mel-14 failed to
exert any influence on the development of aEAE in the SJL mouse
model (Table 1).
Characterization of L-selectin-deficient SJL mice
As L-selectin-deficient MBP-specific TCR transgenic B10.PL mice
and L-selectin-deficient C57BL/6 mice are reported to be resistant
to EAE [8, 9], we anticipated that development of EAE might only
be impaired in the complete absence of L-selectin. L-selectin-
deficient mice were therefore backcrossed to the EAE-susceptible
genetic background of the SJL strain for at least 11 generations
before being analyzed and used in the experiments described. To
ascertain that the phenotype of L-selectin-deficient mice described
in the 129/Sv//C57BL/6 chimeric genetic background [14] is
maintained in the SJL background, lymphoid organ architecture
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was investigated by immunohistochemistry and lymphocyte
numbers were determined. Reproducing the phenotype published
for L-selectin–/– mice in the chimeric background [14], mesenteric
lymph nodes (MLN) of L-selectin–/– SJL mice were found to
resemble those of wild-type mice (data not shown and Table 2). As
reported previously, PLN, i.e., popliteal, inguinal, para-aortical,
axillary and cervical LN, were strikingly smaller in size (data not
shown) and significantly depleted for lymphocytes (Table 2). In
contrast, the spleens of L-selectin–/– SJL mice were enlarged and
harbored a significantly increased number of lymphocytes, when
compared to wild type SJL mice (Table 2). Additionally, L-selectin
deficiency in the SJL background lead to an apparently increased
number of lymphocytes circulating in the blood stream when
compared to wild-type SJL mice, which was found to be not
significant (Table 2). To address, whether lack of L-selectin
expression affects the cell surface expression of adhesion
molecules that have previously been demonstrated to be involved
in EAE pathogenesis, we investigated the surface expression of
a4b1- and a4b7-integrin and LFA-1 on T lymphocytes isolated
from MLN and PLN as well as the spleen. We did not detect any
significant differences between wild-type SJL and L-selectin–/– SJL
mice (data not shown).
L-selectin deficient SJLmice develop EAE upon adoptive
transfer with wild-type PLP-specific T cells
We next asked whether the transfer of PLP-specific CD4+ T cells
can elicit EAE in L-selectin–/– SJL mice, as the observations
reported in the L-selectin-deficient MBP-TCR transgenic B10.PL
mouse and C57BL/6 mouse EAE models are contradictory in this
issue [8, 9]. The transfer of freshly activated encephalitogenic
T cells from PLP-specific CD4+ Th1 cell lines induced EAE in
L-selectin–/– SJL mice in a manner indistinguishable from wild-
type SJL mice (Fig. 1). Furthermore, we did not observe any
difference in the size and cellular composition (CD3+ T cells,
B220+ B cells, Mac-1+ macrophages, CD4+ T cells) of the
inflammatory cuffs in frozen sections of brains and spinal cords of
wild-type and L-selectin–/– SJL mice during EAE. Thus, expression
of L-selectin in the host is not required for the development of
clinical EAE in SJL mice.
Table 2. Numbers of lymphocytes present in peripheral blood, LN and spleen of SJL wild-type and SJL/L-Sel–/– mice
SJL/L-sel–/– SJL wild type Statistical significance
Blooda) 2.3  0.8  107 1.3  0.7  107 Not significant
MLNa) 67  3  105 55  13  105 Not significant
PLN 1.6  0.95  105 44.7  14  105 p=0.0015 very significant
Spleen 4.1  0.4  108 1.9  0.6  108 p=0.0095 very significant
a) Mononuclear cell numbers calculated per mL blood or per lymphoid organ are given. Cell counts were obtained from seven mice per group.
Statistical comparison was performed using an unpaired Student's t-test
Table 1.Mel-14 does not influence the development of aEAE in SJL mice
aEAE Control
antibodya)
Mel-14
No. of SJL/N mice 4 4
No. of SJL/N mice with clinical
disease
4 4
Mean day of onset of disease 15.3  1.5 15.7  1.4
Mean severity of disease 2.6  1.5 2.5  1.8
a) Antibody, 400 lg, was injected i.v. at day –1 before induction of EAE
and at days 4 and 10 after induction of EAE. Presence of saturating
antibody titerswas confirmed by FACS analysis on PLN lymphocytes.
One representative experiment out of three is shown.
Figure 1. PLP-specific wild-type (wt) T cells transfer EAE into syngeneic
wild-type and L-selectin-deficient SJLmice. Average disease scores SD
(top panel) and average weight change  SD (bottom panel) assessed
daily following transfer of encephalitogenic T cell blasts are shown.
Values represent 3 mice per group. One representative experiment out
of four with a total number of 14 mice examined per group is shown.
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Encephalitogenic T cells up-regulate L-selectin
expression in vivo
It has been reported that encephalitogenic T cells change their
surface phenotype in vivo [18]. Thus, although encephalitogenic
T cell blasts transferring EAE do not display any cell surface
expression of L-selectin in vitro (Fig. 2), they might up-regulate
expression of L-selectin in vivo. L-selectin could thus still be
required on encephalitogenic effector T cells to successfully
transfer EAE into syngeneic recipients. To address this, CellTrack-
erTM Green-labeled encephalitogenic T cell blasts were intrave-
nously injected into SJL mice and at 48 and 72 h after injection
spleen, MLN and PLN were harvested and cell suspensions were
stained with Mel-14 to detect surface expression of L-selectin. Due
to the low number of encephalitogenic T cells homing to the brain
and spinal cord early after injection, cell surface expression of
L-selectin on the injected encephalitogenic T cells from these
organs could not be determined. However, L-selectin expression
could clearly be detected on a low percentage of CellTrackerTM
Green-stained encephalitogenic T cells present in the different
secondary lymphoid organs already 48 h after infusion. By 72 h
after infusion all CellTrackerTM Green-positive encephalitogenic
T cells present in PLN and significant subpopulations of these
Tcells present inMLN and the spleen stained positive for L-selectin
(Fig. 2). PLP-specific T cells grown in vitro remained negative for
L-selectin cell surface staining throughout this time (not shown).
Thus, in vivo a subpopulation of encephalitogenic T cells
originating from the transferred T cells up-regulates L-selectin
cell surface expression. Therefore, L-selectin could indeed
contribute to their effector functions required for establishing
clinical EAE.
L-selectin-deficient SJL mice develop active EAE
To study whether EAE can develop in the complete absence of
L-selectin, we next asked, if EAE can be actively induced in
L-selectin–/– SJL mice. Interestingly, we did not observe any
difference in the onset, duration or clinical severity of aEAE in
L-selectin–/–SJL mice in backcrossing generations N16–N18 when
compared to wild-type control mice (Fig. 3). Thus, in the SJL
background L-selectin is not required for the in vivo priming of
encephalitogenic T cells, their trafficking to the CNS or the
subsequentmolecular mechanisms involved in CNS tissue damage,
which all contribute to establish the clinical picture of EAE.
PLP-specific T cells are primed in the spleen
of L-selectin–/– SJL mice
As L-selectin–/– SJL mice have dramatically reduced PLN, we next
aimed to determine, where PLP-specific T cells are primed in
Figure 2. L-selectin is up-regulated on encephalitogenic PLP-specific
T cells in vivo. SJL.PLP6 lymphoblasts were labeled with CellTrackerTM
Green directly after restimulation and intravenously injected into SJL
mice. In parallel, a small subset of labeled T cells was cultured in vitro to
confirm stability of CellTrackerTM labeling and cell surface phenotype.
48 (day 2) and 72 (day 3) h after injection splenocytes, MLN and PLN
cells were harvested and stained for L-selectin using the mAb Mel-14.
Cells were scatter gated for live and green fluorescent cells. In contrast
to in vitro grown SJL.PLP6, which stained negative for L-selectin,
L-selectin expression can be detected on CellTrackerTM-positive
SJL.PLP6 cells present in spleen, MLN and PLN starting at 2 days after
injection. Isotype control staining is shown by a dotted line. One of two
independent experiments is shown.
Figure 3. L-selectin-deficient SJL mice develop active EAE indistinguish-
able fromwild-type SJLmice. aEAEwas induced in L-selectin–/– SJLmice
and syngeneic wild-type control mice. Average disease scores SD (top
panel) and average weight change  SD (bottom panel) assessed daily
following immunization with PLPaa139–151 are shown. Values represent
three mice per group. One representative experiment out of four with a
total number of 22 mice examined per group is shown.
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L-selectin–/– versus wild-type SJL mice in vivo after subcutaneous
immunization with PLPaa139–151 in CFA. We performed in vitro
antigen-recall proliferation assays with lymphocytes isolated from
draining PLN, spleen and blood. In SJL wild-type mice, a
prominent T cell proliferation response to PLPaa139–151 was
detected at 6 days after immunization in the draining PLN and
to a lesser degree in the spleen and the blood (Fig. 4). In contrast,
in L-selectin–/– SJL mice, the PLPaa139–151-specific T cell prolifera-
tion was limited to the spleen and maintained there at a
comparable level to wild-type mice until the beginning of the
disease (day 10 post immunization, p.i.) and during clinical EAE
(day 14 p.i.). Although a detectable PLP-specific T cell response is
mounted in the PLN of L-selectin–/– SJL mice in parallel to the
onset of clinical EAE, it remained significantly lower than that
observed in PLN of wild-type SJL mice (Fig. 4). To test if the
reduced PLP-specific T cell proliferation observed in PLN of
L-selectin–/– SJL mice is due to a general proliferation defect of
L-selectin-deficient T lymphocytes, we tested their proliferation to
polyclonal stimuli such as Con A and anti-CD3/anti-CD28
stimulation and did not observe any significant difference (data
not shown). Once clinical EAE started (day 10 p.i.), a comparable
number of PLP-specific T cells was observed in the peripheral
blood of both wild-type and L-selectin–/– SJL mice. Thus, in
L-selectin–/– SJL mice, PLP-specific T cells are predominantly
primed in the spleen and later and to a lesser degree in the PLN.
Nonetheless, these T cells travel to the CNS at the same time as in
wild-type mice since they can be detected in identical amounts in
the peripheral blood.
Figure 4. Lack of L-selectin affects the localization of PLP-specific T cell priming in SJL mice. Graphs show PLPaa139–151–induced T cell proliferation
in primary cultures of draining PLN, spleen and blood obtained fromwild-type (grey lines) and L-selectin–/– (black lines) SJLmice at 6, 10 and 14 days
p.i. with PLPaa139–151/CFA for increasing PLPaa139–151 concentrations in lg/mL. Stimulated proliferation normalized against baseline proliferation in
the absence of any stimulus is shown as incorporation of [3H]thymidine, values represent mean cpm  SD (n=3). Compared to wild-type mice, the
PLP-specific T cell response is reduced and delayed in PLN and the blood of L-selectin-deficient mice. In contrast, the PLP-specific T cell proliferation
observed in splenocyte cultures is comparable in both mice. *p<0.05, **p<0.01.
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Ovalbumin-specific T cells are primed in the spleen of
L-selectin–/– SJL mice
It has been shown that SJL mice harbor a high frequency of
PLPaa139–151–specific T cells due to their escape from central
tolerance, as intrathymic expression of PLP is restricted to the
shorter splice variant DM20 [19, 20]. Thus, specifically in SJL
mice, lack of L-selectin might have less impact on the priming of
encephalitogenic PLPaa139–151–specific T cells as compared to the
priming of T cells with other antigen-specificities. We therefore
immunized L-selectin-deficient SJL mice and wild-type SJL mice
subcutaneously with the model antigen OVA in CFA and compared
the in vitro antigen-recall proliferation of OVA-specific T
lymphocytes isolated from the draining PLN and the spleen.
Similar to our observations made after immunization with
PLPaa139–151, SJL wild-type mice exhibited a prominent OVA-
specific T cell proliferative response in the draining PLN and to a
lesser degree in the spleen already at 6 days p.i. (Fig. 5). In both
Figure 5. Lack of L-selectin affects the localization of OVA-specific T cell priming in SJL mice. Graphs show OVA-induced T cell proliferation in
primary cultures of draining PLN and spleens of wild-type(straight lines) and L-selectin–/– (dashed lines) SJLmice at 6, 10 and 14 days p.i. with OVA in
CFA for increasing OVA concentrations (lg/mL). Proliferation normalized against baseline proliferation in the absence of any stimulus is shown as
incorporation of [3H]thymidine, values representmean cpm SD (n=3). Compared towild-typemice, theOVA-specific T cell response is significantly
delayed in PLN and spleen of L-selectin–/– SJLmice, but increasing in both the PLN and the spleen at days 10 and 14 p.i., reaching levels comparable to
SJL wild-type mice at day 10 p.i. in the spleen and day 14 p.i. in the PLN. *p<0.05, **p<0.01, ***p<0.001.
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secondary lymphoid organs the OVA-specific T cell response
further increased at 10 and 14 days p.i. in SJL wild-type mice. In
L-selectin–/– SJL mice, a significantly reduced OVA-specific T cell
proliferation was measured in the PLN and the spleen 6 days after
immunization. However, also in L-selectin–/– SJL mice the OVA-
specific T cell proliferation was found to be increased at 10 and
14 days p.i., reaching comparable levels to the OVA-specific T cell
proliferation in SJL wild-type mice. Thus, in L-selectin–/– SJL mice,
priming to a subcutaneously applied model antigen is not
generally impaired but rather leads to a compensatory shift of
antigen-specific T cell priming to the enlarged spleens of these
mice when compared to SJL wild-type mice.
L-selectin deficient PLP-specific T cells transfer EAE into
wild-type and knockout mice
After identifying the spleen as the immune organ, where antigen-
specific T cells are primed in L-selectin–/– SJL mice, we set out to
investigate whether L-selectin–/– PLP-specific T cell blasts can
transfer EAE into wild-type and L-selectin–/– SJL mice. We isolated
splenocytes from L-selectin–/– SJL mice subcutaneously immu-
nized with PLPaa139–151 in CFA 10 days earlier. These were
activated with their specific antigen for 4 days in vitro, and
1  107 PLP-specific Tcell blasts (Fig. 6A) were then intravenously
injected into syngeneic wild-type and L-selectin–/– mice.
L-selectin–/– PLP-specific T cells were found to transfer EAE to
both wild-type SJL and L-selectin–/– SJL mice (Fig. 6B). We did not
observe any significant difference in the onset, severity or duration
of disease. Thus, effector T cells do not require L-selectin to
transfer EAE in the SJL mouse.
L-selectin is not required for inflammatory cell entry
into the CNS parenchyma during EAE in the SJL mouse
Perivascular infiltrates in the brains and spinal cords of EAE-
resistant L-selectin–/– MBP-TCR transgenic B10.PL mice were
found to be restricted to the perivascular space, suggesting that in
this model L-selectin is required for extravasation of inflammatory
cells across the glia limitans into the CNS parenchyma [9]. We
therefore investigated the localization of CD45+ inflammatory
cells in the brains of wild-type and L-selectin–/– SJL mice during
clinical EAE induced either by the transfer of wild-type or
L-selectin-deficient PLP-specific T cells. Performing double
immunofluorescence staining on frozen brain sections of these
mice suffering from EAE demonstrated that independent of the
absence or presence of L-selectin on the encephalitogenic Tcells or
in the host, CD45+ inflammatory cells were able to leave the
perivascular space marked by laminin-positive borders (Fig. 7).
Furthermore, we did not observe any difference in the size and
cellular composition (CD3+ T cells, B220+ B cells, Mac-1+
macrophages, CD4+ Tcells) of the inflammatory cuffs in the brains
of wild-type and L-selectin–/– SJLmice during clinical EAE induced
either by the transfer of wild-type or L-selectin-deficient PLP-
specific T cells (data not shown). Thus, in SJL mice, L-selectin is
neither required for inflammatory cell migration across the
endothelial BBB nor for their immigration into the CNS
parenchyma.
Figure 6. L-selectin-deficient PLP-specific T cells transfer EAE to
syngeneic wild-type and L-selectin-deficient SJL mice. (A) PLP-specific
proliferation of L-selectin-deficient T cells to be used in transfer EAE
experiments was ascertained by measuring the incorporation of
[3H]thymidine in response to PLPaa139–151, compared to the control
protein PPD, the T cell mitogen Con A and medium as a control. Bars
represent mean  SD (n=3). (B) L-selectin-deficient PLP-specific T cells
transfer EAE into wild-type and L-selectin–/– SJL mice. One representa-
tive experiment out of 5 with a total number of 20 mice per group
examined is shown. The apparently shorter disease duration is not
statistically significant.
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L-selectin-deficient C57BL/6 mice develop active EAE
Based on our present findings that L-selectin is not required for the
priming, clonal expansion and effector function of encephalito-
genic T cells during EAE in SJL mice, the previous observations
that L-selectin-deficient C57BL/6 mice are resistant to EAE due to
their failure to mount an encephalitogenic T cells response is quite
surprising. Resistance to EAE was observed in L-selectin-deficient
C57BL/6 mice in backcrossing generation N10 [8]. To find out
whether more extensive backcrossing of L-selectin-deficient mice
into the C57BL/6 background, as performed by us for the SJL
mice, has any influence on EAE development, we investigated the
development of MOG-induced EAE in L-selectin–/– C57BL/6 mice
in backcrossing generation N18. Interestingly, we found that
L-selectin–/–C57BL/6 mice were susceptible to MOG-induced
active EAE (Fig. 8), demonstrating that L-selectin–/– C57BL/6
mice in N18 can mount an encephalitogenic T cell response in the
absence of L-selectin.
Discussion
In this study we demonstrate that the lack of L-selectin does not
confer resistance to EAE in the SJL mouse. Our studies with
L-selectin–/– SJL mice demonstrate that in this model L-selectin is
not required for the priming, clonal expansion or effector function
of encephalitogenic T cells, or for inflammatory cell trafficking
across the BBB and into the CNS parenchyma during EAE. Transfer
EAE studies with wild-type and L-selectin–/– SJLmice as recipients,
and wild-type and L-selectin–/– PLP-specific T cell lines, confirmed
that L-selectin is not needed on encephalitogenic T cells or in the
syngeneic recipient for the development of the full clinical and
histopathological picture of EAE. Antibody inhibition studies with
the anti-L-selectin antibody Mel-14 performed in PLPaa139–151–
induced EAE in the SJLwild-typemouse failed to interfere with the
clinical development of EAE, and thus confirm the observations
made in the L-selectin–/– SJL mouse. Finally, L-selectin–/– C57BL/6
mice in backcrossing generation N18 were found to be susceptible
to EAE.
Our observations are in apparent contrast to those made in the
Lewis rat EAEmodel, where anti-L-selectin antibodies were shown
to suppress EAE induced by immunization with MBP [15].
Interestingly, the very same study demonstrated that anti-L-
selectin antibodies do not interfere with EAE induced by the
adoptive transfer of encephalitogenic T cells [15], suggesting that
blocking of L-selectin in this EAE model targets priming of
encephalitogenic T cells in vivo rather than T cell trafficking into
the CNS. A lack of involvement of L-selectin in T cell migration
across the BBB is supported by the findings that Mel-14 does not
inhibit the development of clinical EAE induced by transfer of PLP-
specific Tcells into (PLxSJL)F1 mice due to its failure to block Tcell
homing to the CNS [7]. The finding that lack of L-selectin does not
prevent leukocyte trafficking across the endothelial BBB in general
is further supported by active EAE studies performed in MBP-TCR
transgenic B10.PL mice [9]. Although B10.PL mice on a L-selectin
null background are resistant to clinical EAE, inflammatory cells
were still found to accumulate in the brains and spinal cords of
these mice after immunization with MBP. Thus, all EAE models
investigated have produced evidence that L-selectin is not required
for immune cell migration across the BBB.
Interestingly, the perivascular infiltrates observed in the brains
and spinal cords of the L-selectin–/– MBP-TCR transgenic B10.PL
mice [9] remain clinically silent. Such clinically silent perivascular
infiltrates limited by the endothelial and the parenchymal
basement membranes have been observed before in EAE studies
Figure 7. CNS parenchymal infiltration by CD45+ inflammatory cells
during EAE is independent of the presence of L-selectin on encepha-
litogenic T cells or in the host. Double immunofluorescence staining for
CD45 (green) and laminin (red) of frozen brain sections frommice with
EAE are shown. Staining demonstrates that the presence of CD45+
inflammatory cells outside of the laminin-bordered perivascular space
is independent of the transfer of EAE by either wild-type (SJL. PLP57) or
L-selectin-deficient (SJL/L-Sel.PLP20) PLP-specific T cells and is also
independent of the presence or absence of L-selectin within the host.
Bar 50 lm.
Figure 8. L-selectin-deficient C57BL/6 mice are susceptible to MOG-
induced active EAE. aEAE was induced in L-selectin–/– C57BL/6 mice
(backcrossing generation N18) and syngeneic wild-type control mice.
Average disease scores  SD assessed daily following immunization
with MOGaa35–55 are shown. Values represent four mice per group. One
representative experiment out of two is shown.
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performed in C57BL/6 mice deficient for matrix metalloprotei-
nases-2 and –9 [21] or for TNF-a [22] and also in the SJL mouse
EAE model after depletion of macrophages [23]. In this context it
is remarkable that clinical EAE could be induced in the
L-selectin–/– MBP-TCR transgenic B10.PL mice by the adoptive
transfer of wild-type macrophages [9], and F4/80+ macrophages
could then be detected in the CNS parenchyma of these mice. As
neither the activation of MPB-specific Tcells nor inflammatory cell
recruitment across the endothelial BBB was impaired in the MBP-
TCR transgenic L-selectin–/– B10.PL mice, these observations
suggest an involvement of L-selectin in macrophage extravasation
to the CNS parenchyma and/or the destruction of myelin during
the effector phase of EAE. In this context it is important to note that
CNS myelin harbors not-yet-defined L-selectin ligands, which
mediate lymphocyte binding in vitro [24, 25]. The necessity of
L-selectin engagement of a myelin ligand as a prerequisite for the
development of clinical EAE could, however, neither be observed
in L-selectin–/– SJL mice in the present study nor in L-selectin–/–
C57Bl/6 mice [8]. In the latter study performed in the C67BL/6
model it was found that MOG-specific T cells transfer EAE into
sublethally irradiated syngeneic recipients independent of the
presence or absence of L-selectin on the encephalitogenic Tcells or
the recipient [8]. These observations are in accordance to those
made by us in the SJL mouse, where we did not find any difference
in the development of EAE transferred by PLP-specific T cells into
syngeneic recipients irrespective of the presence or absence of
L-selectin on PLP-specific Tcells or in the recipient. A requisite role
of L-selectin on macrophages for invasion of the CNS parenchyma
during EAE and tomediate myelin damage was thus only observed
in MBP-TCR transgenic B10.PL mice, but could not be validated in
EAE studies performed in L-selectin–/– C57Bl/6 or SJL mice. A
requirement of L-selectin for the development of clinical EAE may
thus be a unique feature of the MBP-TCR transgenic B10.PL mouse
model, where monoclonal myelin-specific T cell activation might
overemphasize a role for L-selectin in triggering the effector
function of macrophages required to establish clinical EAE.
Due to their lymphocyte homing defect, L-selectin–/–mice have
dramatically reduced PLN irrespective of their inbred strain
background. Thus, an impaired or delayed priming of encepha-
litogenic T cells upon induction of active EAE by subcutaneous
immunization with myelin antigens in CFA is expected. Surpris-
ingly, L-selectin–/– SJL mice in backcrossing generations N11–N18
did not show any difference in the clinical development of aEAE
when compared to wild-type SJL mice. Nevertheless, we found
that L-selectin deficiency does indeed compromise the priming of
both PLP- and OVA-specific Tcells in the PLN. In contrast, antigen-
specific T cell proliferation in the spleens of L-selectin–/– SJL mice
is not affected. Independent of the organ location of their priming,
PLP-specific T cells were then detectable in equal amounts in the
peripheral blood of both wild-type and L-selectin–/– SJL mice at
day 10 p.i. right before disease onset. Thus, in the L-selectin–/– SJL
mouse there is a compensatory shift of PLP-specific T cell priming
from PLN to the enlarged spleens, resulting in the lack of any
impact on EAE development. Interestingly, in theMBP-TCR B10.PL
mice, Tcell priming upon immunization withMBPwas found to be
generally unaffected on the L-selectin–/– background in both the
spleen but also the PLN [9]. This surprising findingmight be due to
the unphysiologically high numbers of antigen-specific T cells
already pre-existing in the extremely small PLN of L-selectin–/–
MBP-TCR transgenic B10.PLmice. This assumption is supported by
the observation that, similar to our observations made in
L-selectin–/– SJL mice, L-selectin–/– C57BL/6 mice demonstrate
a profound defect in the priming of myelin-specific T cells in the
PLN upon induction of active EAE [8]. In contrast to our findings,
L-selectin–/– C57BL/6 mice in backcrossing generations N10 were
previously reported to be fully resistant to the induction of active
EAE due to their complete failure to mount a MOG-specific T cell
response in both the PLN and the spleen [8]. Using L-selectin–/–
C57BL/6 mice more extensively backcrossed to the C57BL/6
background (N18), we have found these mice to be quite
susceptible to the development of aEAE. Our observations in
L-selectin–/– C57BL/6 mice (N18) are quite analogous to those in
L-selectin–/– SJL mice, where, upon extensive backcrossing
(N11–N18), susceptibility of EAE mirrors that of control SJL
mice. The apparent discrepancy in susceptibility to EAE in
L-selectin–/– C57BL/6 mice in the previous study compared to
our present investigation may thus be attributable to the further
backcrossing, subtleties in the EAE induction process, animal
housing or other factors.
Taken together, our findings and those by others are in
agreement regarding that L-selectin is not required for immune
cell migration across the BBB during EAE, irrespective of the EAE
model investigated. In the SJL mouse, lack of L-selectin has no
impact on the priming, clonal expansion and effector function of
encephalitogenic T cells and the development of active or passive
EAE. Formally it cannot be excluded that the observed involve-
ment of L-selectin in EAE pathogenesis is due to a closely linked
genetic locus modifying L-selectin activity, which could not be
separated by backcrossing for 6 or 10 generations as performed in
the previous studies. Our observations demonstrating EAE
susceptibility of L-selectin–/– C67BL/6 mice in backcrossing
generation N18 support the notion that in higher backcrossing
generations absence of L-selectin does not confer protection to
aEAE. Finally, it will be important and quite valuable for the
interpretation of results obtained in related experimental
strategies to find out whether the involvement of L-selectin in
triggering effector functions of CNS macrophages during EAE is a
unique requirement only observable in an EAEmodel investigating
TCR-transgenic mice.
Material and methods
Mice
All animal procedures were performed in accordance with the
Swiss and the US legislation on the protection of animals and
approved by the respective government authorities. SJL mice were
obtained from Taconic (Bomholt, Denmark) and Harlan Winkel-
mann (Horst, The Netherlands), C57BL/6 mice from Jackson
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Laboratories (Bar Harbor, ME). L-selectin-deficient mice [14] were
backcrossed into the EAE susceptible SJL background and used for
analysis starting from the 11th backcrossing generation. Most
experiments shown in the manuscript were performed with SJL
mice in backcrossing generations N15–N18. L-selectin–/– C57BL/6
mice were used in backcrossing generation N18.
Genotyping of mice
The genotype of mice was confirmed by PCR from tail biopsies
before and after the experiments. PCR were performed on a
Mastercycler ep gradient S (Vaudaux-Eppendorf, Schnenbuch,
Switzerland) in 20-lL reactions with primers at 0.65 lM each,
dNTP at 0.2 mM, 1 U Taq polymerase (Promega) containing 1 lL
proteinase K-treated lysates from tail biopsies. PCR cycling was
always preceded by a 4-min denaturation step at 94C and
followed by a 10-min final extension step at 72C.
Wild type: FW150-TGC CTGGTC CTAGAACAC TC-30, Rev1 50-
GTG GTC CCA CAT CAG CGT AG-30; PGKneo: FW2 50-TGT GCC
TGGTCC TAGAAC ACT C-30, PGK-Rev2 50-TGTCACGTCCTGCAC
GAC GC-30. PCR was conducted for 35 cycles of 45 s. at 94C, 45 s
at 60C, 60 s at 72C. The resulting PCR products are 480 bp in
size for the wild-type allele and 596 bp for the PGK neo allele.
Primers Tie1-FW3 (50-CGA AGG GAT GGG AGA GAG AGC-30)
and Tie1-Rev2 (50-TGA CGC TAT GAC GAC GAC GAT G-30) were
included in the amplification of an internal control product from
the mouse Tie-1 gene.
Peripheral blood and LN lymphocyte counts
Mice were killed, blood was collected and draining LN and spleen
were removed. Single-cell suspensions were produced and cell
numbers were determined using the CASY TT Cell counter
(Schrfe System, Reutlingen, Germany).
Antibodies
Anti-mouse CD28 and FITC-conjugated CD45 were purchased
from BD Pharmingen (Basel, Switzerland); anti-mouse CD3e was
purchased from Milan Analytica AG (La Roche, Switzerland).
MEC13.3 (anti-mouse PECAM-1) was a kind gift of Dr. E. Dejana
(Milano, Italy). Supernatants of the hybridomas Hermes-1 (9B5,
anti-human CD44, used as an isotype-matched control), Mel-14
(anti-L-selectin), M1/9 (anti-mouse CD45), M1/70 (anti-mouse
Mac-1), and GK1.5 (anti-mouse CD4) were produced in our own
laboratory and used undiluted. For in vivo use endotoxin free
antibody preparations were obtained from serum free culture
medium by ammonium sulfate precipitation as described before
[16]. Polyclonal rabbit anti-laminin antibody (used at 1:200 in
immunofluorescence) and rabbit anti-human von Willebrand-
Factor (vWF) antibody (used at 1:800 in immunofluorescence)
were purchased from Dako Diagnostic AG (Zug, Switzerland).
Immunohistology and immunofluorescence
Mice were anesthetized with isoflurane (Baxter, Arovet AG,
Zollikon, Switzerland) and perfused with 1% paraformaldehyde
(Grogg Chemie AG, Stettlen/Deisswil, Switzerland) in PBS
through the left ventricle of the heart. Brains and spinal cords
were removed, embedded in Tissue-Tek (OCT compound, Haslab,
Ostermundingen, Switzerland), snap frozen in an isopentane/dry
ice bath (Grogg Chemie AG) and stored at –80C. For
immunohistology, cryostat sections (6 lm) were air-dried over-
night, acetone fixed and stained using a three-step immunoper-
oxidase staining kit (Vectastain, Reactolab SA, Servion, Switzer-
land) according to the manufacturer's protocol exactly as
described before [3]. For immunofluorescence staining, sections
were blocked for 20 min with skimmed milk, incubated for 1 h
each with primary and secondary antibody diluted in skimmed
milk, with Tris-buffered saline (TBS) washing steps in between.
After a final TBS wash, sections were mounted in Mowiol
(Calbiochem, Grogg Chemie AG).
Induction of EAE in SJL mice
Active EAE was induced by immunizing 8–12-week-old female
wild-type and L-selectin-deficient SJL mice with 50 lg
PLPaa139–151 in complete Freund's adjuvant (Santa Cruz, LabForce,
Nunningen, Switzerland) supplemented with 4 mg/mL nonviable,
desiccated Mycobacterium tuberculosis (H37RA, Difco BD
Bioscience Clontech, Allschwill, Switzerland) subcutaneously
exactly as described [6]. Per mouse, 3  109 attenuated Bordetella
pertussis organisms (kindly provided by Crucell-Berna Biotech AG,
Bern, Switzerland) were administered intravenously in 0.1 mL
PBS at days 1 and 3 p.i. Passively transferred EAE was induced in
SJL mice by intravenous injection of 3  106 freshly activated
syngeneic encephalitogenic CD4+ PLP-specific T cells or as
indicated for the individual experiments [5, 16]. The PLP-specific
Th1 memory/effector T cell lines SJL.PLP2 to SJL.PLP9 raised
against the PLP peptideaa139–151 have been described in detail
before [16, 26]. In agreement with the requirement of the local
government, assessment of clinical disease activity was performed
twice daily as described before [6] by documenting the clinical
severity EAE using a four-point-scoring system as follows:
0, healthy; 0.5, limp tail; 1, hind leg paraparesis; 2, hind leg
paraplegia; and 3, hind leg paraplegia with incontinence. Note
that at clinical score 2 mice are still motile, whereas at clinical
score 3 motility of animals begins to be impaired. Additionally, in
the SJL EAE model we documented the weight changes during the
disease course as we have found this to be a valuable additional
measure for disease activity.
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Induction of EAE in C57BL/6 mice
Induction of active EAE in C57BL/6 was performed exactly as
described for SJLmice above, with the sole difference that EAEwas
induced by subcutaneous immunization of 6-week-old female
C57BL/6 and L-selectin-deficient C57BL/6 mice (in backcrossing
generation N18) with 200 lg MOGaa35–55 in CFA, supplemented
with 4 mg/mL nonviable, desiccated M. tuberculosis. C57BL/6
mice were scored according to their clinical severity as follows:
grade 0, no abnormality; grade 1, limp tail; grade 2, limp tail and
hind limb weakness (waddling gait); grade 3, partial hind limb
paralysis; and grade 4, complete hind limb paralysis.
In vivo homing assays and flow cytometry
PLP-specific T cell blasts were labeled with 20 nM CellTrackerTM
Green in RPMI 1640 with 10% FBS at 5  106 cells/mL and 37C
for 45 min exactly as described before [27]. PLP-specific
CellTrackerTM Green-labeled T cell blasts (1  107) were injected
i.v. into syngeneic recipients and spleen, MLN and PLN were
harvested at the indicated time points and cell suspensions were
prepared. The percentage of CellTrackerTM green-stained Tcells in
LN and spleen suspension and cell surface expression of L-selectin
were analyzed by flow cytometry. FACS analysis for cell surface
antigens was performed exactly as described before [5]. Flow
cytometric analysis was performed on a FACSCalibur using
CellQuest software (Becton Dickinson, Heidelberg, Germany).
T cell proliferation
Wild-type and L-selectin-deficient SJL mice were immunized with
PLPaa139–151 exactly as described above omitting injection of
B. pertussis organisms. Similarly, immunization with OVA (Sigma-
Aldrich, Switzerland) was performed by subcutaneous injection of
100 lg OVA in CFA. At the days indicated, mice were killed, blood
was collected and draining LN (popliteal and inguinal) and spleen
were removed. Single-cell suspensions were produced and cells
were seeded in 96-well plates at 2  105 cells/well in RPMI 1640
supplemented with 10% FBS (GIBCO, LuBiosience, Lucerne,
Switzerland), 10 U/mL penicillin/streptomycin, 2 mM L-gluta-
mine, 1% nonessential amino acids, 1 mM sodium pyruvate and
0.05 mM b-mercaptoethanol (Grogg Chemie AG). PLPaa139–151 or
OVA diluted in RPMI 1640 was added in increasing concentrations
to test for antigen-specific T cell proliferation. T cell proliferation
induced by the mitogen Con A (2.5 lg/mL) was used as a positive
control for T cell proliferation. All samples were plated in
triplicates. [3H]Thymidine (1 lCi/mL) was added 16 h prior to
harvesting the cultures on glass fiber filters using a cell harvester
(Inotech, Dottikon, Switzerland) and incorporation of [3H]thy-
midine was measured by liquid scintillation counting.
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